Partner Content Partner Content J+D Forecasting launches innovative pharmaceutical sales for... Sales+ is the first Excel add-in that provides all the
News UK biotech PhoreMost to work with Otsuka on gene therapy pro... Building on an R&D tie-up with an Indian stem cell institution last year, UK biotech PhoreMost has begun a collaboration with Japan’s Otsuka working on several gene therapy projects.
Partner Content Partner Content New Dates Released for J+D's Pharma Forecasting Training J+D releases new forecasting training dates
Events Partner Content Pharma and Biotech IP 2020 Next-generation strategy for cutting-edge innovation
Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
